GIGABYTE
26.3.2020 11:02:27 CET | Business Wire | Press release
(GIGABYTE) As the new Coronavirus rages around the world, many countries have announced lockdown of cities or regions. Many enterprises have begun implementing Work-from-Home policies to protect employees from infection. For those who are already working from home, you fed-up with the performance of your old computer? As for those who have not been quarantined, are you well-prepared to work from home? As a leading laptop manufacturer, GIGABYTE now provides selection guides for different consumer groups and offers excellent discounts. With GIGABYTE’s ultra-performance laptops, not only can you work effortlessly from home, but can also enjoy binge-watching and gaming thanks to their excellent display and immersive sound effects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200326005025/en/
As the pandemic spreads, how to work efficiently from home as well as pass time has become the focus of many people. "In addition to laptops’ performance and image quality, what concerns people working from home includes network quality, having enough ports to connect to devices such as screens, convenience of use in every corner of the house (such as the sofa or bed), and the long battery life," says Steven Chen, VP of GIGABYTE Mobility Product Business Group.
Wireless signal too weak? Not enough ports?
GIGABYTE’s AERO and AORUS Series have taken all these concerns into account. For the wireless network coverage and communication quality issues caused by the home environment, GIGABYTE combines Killer Wireless xTend technology to turn its laptops into a wireless range extender, which extends both wired and wireless networks. The latter can even be extended to cover 90 square meters, eliminating all household notspots. Besides, both series have up to nine external ports, including audio and video transmission ones for Display, HDMI, and Thunderbolt. Want to connect to a larger screen at home? You don’t have to waste money on a bunch of adapters anymore. GIGABYTE’s laptops also feature 94Wh batteries, the high capacity of which is twice that of other products in the industry, allowing laptops to work for more than 8-9 hours in high-performance mode.
Fight the Coronavirus together! Special offers for Intel Gen9 high-performance models!
Amid the Coronavirus outbreak, GIGABYTE has launched discounts for different consumer groups, directly launching models that have received both domestic and international recognition, including European Hardware Association’s Best Notebook 2019 and Taiwan Excellence Awards. Since all the discounted laptops have Intel's ninth-generation Core i7 processor, NVIDIA RTX / GTX series graphics cards and are equipped with Windows 10, whether you are someone who has to work from home or just looking for fun, you can easily find a laptop with favorable discounts that fits your personal needs!
For creators pursuing 4K UHD of HDR400 on video/audio quality - AERO 15 OLED
The AERO 15 OLED features the AMOLED 4K UHD screen, high color saturation of HDR400 Certified, ultra-high contrast, 3mm narrow border, ultra-rich and colorful image quality, and supports 100% DCI-P3 color gamut, which is far better than ordinary LCD screens’ 40% NTSC color performance. Having acquired the TÜV Rheinland's hardware low blue light certification, the AERO 15 OLED can reduce harmful blue light by more than 10% compared with ordinary screens, and protect eyes from long-hours of creative work and binge-watching. With the only X-Rite Pantone certified screen in the industry, each panel of the AERO series undergoes independent color correction, allowing its screen color to match the accuracy of the Pantone Matching System!
For people focusing on both business and entertainment – AERO 15 Classic
With a sharp and appealing appearance, the business-like AERO 15 Classic features a thickness of 1.8cm and a weight of 2.0 kg, allowing high portability for working outside once the pandemic ends. Moreover, the performance of NVIDIA GTX / RTX or above is also more than enough to play games. The AERO 15 Classic comes in various panel options, such as the 4K UHD or 144Hz/240Hz gaming monitors, allowing you to enjoy a 4K high image quality or a high refresh rate above 144Hz and to play games without stuttering. It also features X-Rite Pantone certified screens with each panel undergoing independent color correction.
For real hardcore gamers – AORUS 15
The AORUS 15 is the most powerful laptop with a thickness below 2.4cm, Intel Core i7 processor, the highest NVIDIA RTX 2060 graphics card, and unique WINDFORCE Infinity cooling technology, even the waste heat generated by the CPU and GPU can be processed independently without compromising performance. Its sharp 240Hz gaming specifications feature a super high refresh rate, allowing 3A game masterpieces to run smoothly without delay or lag.
For people pursuing high storage capacity with 144Hz display - AORUS 5/7
With the super-optimal 144Hz screen rarely seen among gaming laptops of the same level, the AORUS5/7 weighs 2.15KG and has a thickness of only 23mm, allowing gamers to enjoy lightweight and portability. Its hybrid SSD+HDD drive provides both access speed and large capacity, up to 3 storage interfaces. With a capacity of up to 6TB, you can store large amounts of games or videos without the need of external hard drives.
*For more information, please visit GIGABYTE/AORUS website:
Germany (Deutsch) |
|
France (Français) |
|
Spain (Español) |
|
United Kingdom (English) |
|
Netherlands (Dutch) |
*For more photos, please download here: https://drive.google.com/open?id=1OpkPIRJ6Pc1vSTnW7IehumMRE2YcqHax
GIGABYTE also offers quantity discounts to enterprises. In addition to greater discounts, enterprises can enjoy an extended warranty. For more information, please contact: gswe@gigabyte.com
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005025/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom